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ABSTRACT
Local tissue infiltration of Medulloblastoma (MB) tumor cells precedes metastatic 
disease but little is still known about intrinsic regulation of migration and invasion 
in these cells.
We found that MAP4K4, a pro-migratory Ser/Thr kinase, is overexpressed in 30% 
of primary MB tumors and that increased expression is particularly associated with the 
frequently metastatic SHH β subtype. MAP4K4 is a driver of migration and invasion 
downstream of c-Met, which is transcriptionally up-regulated in SHH MB. Consistently, 
depletion of MAP4K4 in MB tumor cells restricts HGF-driven matrix invasion in vitro 
and brain tissue infiltration ex vivo. We show that these pro-migratory functions of 
MAP4K4 involve the activation of the integrin β-1 adhesion receptor and are associated 
with increased endocytic uptake. The consequent enhanced recycling of c-Met caused 
by MAP4K4 results in the accumulation of activated c-Met in cytosolic vesicles, which 
is required for sustained signaling and downstream pathway activation.
The parallel increase of c-Met and MAP4K4 expression in SHH MB could predict 
an increased potential of these tumors to infiltrate brain tissue and cause metastatic 
disease. Molecular targeting of the underlying accelerated endocytosis and receptor 
recycling could represent a novel approach to block pro-migratory effector functions 
of MAP4K4 in metastatic cancers.
INTRODUCTION
Medulloblastoma (MB), the most common 
malignant brain tumor in childhood, arises in the 
cerebellum, locally infiltrates and has the propensity for 
leptomeningeal spread through the cerebrospinal fluid 
(CSF). MB is molecularly classified into the subgroups 
WNT (Wingless), SHH (Sonic hedgehog) p53-wild-type 
and SHH p53-mutant and groups 3 and 4 [1]. Large-scale, 
genome-wide DNA methylation and gene expression 
analyses combined with copy number aberrations and 
clinical features have recently allowed to further refine 
the four subgroup classification of MB [2] into a total of 
12 subtypes [3, 4]. Of particular significance is the finding 
that SHH β subtype tumors are frequently metastatic, a 
feature that has so far not been attributed to the SHH 
subgroup and that is mechanistically not understood [4]. 
With aggressive treatment modalities, survival rates across 
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all MB subgroups of approximately 70% can be reached 
[5]. However, metastatic and recurrent MB remains 
clinically very challenging with high mortality rates.
Growth factor-driven cancer cell infiltration relies 
on elevated vesicle trafficking for membrane receptor 
turnover and extracellular matrix (ECM) remodeling 
[6, 7]. Endocytic turnover of receptor tyrosine kinases 
(RTKs) for example such as c-Met [8], FGFR [9] or 
EGFR [10] determines strength, specificity and duration 
of signaling. In addition, the redistribution of the 
integrin adhesion receptors through endocytic recycling 
is also critical for cell migration. Integrin engagement, 
activation and recycling is required for the formation 
of invasive structures such as filopodia [11, 12], which 
direct cell migration in complex tissue environments. 
Indeed, the aberrant recycling, activation and/or cell 
surface presentation of integrins can enhance the 
invasive behavior of cancer cells [13–15]. Consequently, 
ß1 integrin trafficking has been identified as a novel 
therapeutic target for anti-metastatic therapy [16]. 
However, how growth factor signaling is coupled to 
receptor trafficking is incompletely understood in general 
and its potential implication in pediatric brain cancers has 
not been investigated.
One kinase linking both integrin activation and 
RTK signal transmission towards migration and invasion 
is the serine/threonine protein kinase MAP4K4 [17]. 
Genetic interference and gene expression analyses 
have implicated MAP4K4 activity in a plethora of 
cellular functions relevant for physiological and 
pathophysiological processes, including organ 
development, systemic inflammation, metabolic disorders 
and in particular cancer [17, 18]. MAP4K4 functions 
downstream of the c-Met receptor tyrosine kinase in MB 
cells to control migration and invasion [19]. Moreover, 
high expression of MAP4K4 in lung adenocarcinoma 
is sufficient to activate the MAP kinase ERK for cancer 
growth and dissemination [20].
Here, we investigated the relationship between 
the increased expression of MAP4K4 and the biology of 
migration and invasion in MB. We addressed how actin-
targeting functions of MAP4K4 are coupled to migration 
and invasion and specifically focused on the regulation of 
receptor turnover in response to growth factor stimulation 
and matrix adhesion.
RESULTS
The Ser/Thr kinase MAP4K4 is overexpressed in 
primary medulloblastoma
MAP4K4 expression is associated with tumor 
progression and metastasis in different solid tumors [20–
24]. MAP4K4 mRNA expression is also increased in MB 
samples derived from several patient cohorts compared 
to normal cerebellum (cb) or normal brain (Figure 1A). 
The analysis of affymetrix human gene 1.1 ST array 
profiling of a recently assembled set of 763 primary 
MB samples used for subtype identification revealed 
increased MAP4K4 expression in the SHH subgroup, with 
particular enrichment in the SHH-α, β and δ subtypes [4] 
(Figure 1B). The majority of high MAP4K4 SHH tumors 
also express high levels of the c-Met receptor tyrosine 
kinase (Figure 1C), which is also particularly enriched 
in all four SHH subtypes (Supplementary Figure 1A). 
To gain insight in MAP4K4 protein expression in human 
MB tumor tissue, we scored MAP4K4 expression levels 
by immunohistochemistry (IHC) into negative, low, 
moderate and high in a MB tissue micro array (TMA) 
containing 68 human tumor samples and 7 cb controls. We 
observed increased MAP4K4 in MB tissue compared to 
adjacent cb, with some tumors showing very high levels 
of MAP4K4 (Figure 1D). IHC also detected high levels 
of MAP4K4 protein expression in a non-WNT/SHH MB, 
moderate levels in a group 3 patient-derived xenograft 
(PDX) and very high expression levels in a Ptch/P53 
null genetic mouse model (Figure 1E). Thus, MAP4K4 
expression is increased in MB compared to healthy 
cerebellum and increased levels can be detected both at 
the mRNA and the protein levels.
MAP4K4 promotes clonogenicity in SHH 
MB cells
We next assessed MAP4K4 mRNA (Supplementary 
Figure 1B) and protein (Figure 2A) expression levels 
in established laboratory or PDX SHH or G3 lines to 
identify a model cell line for further molecular analysis 
of MAP4K4 function. Variable expression levels were 
seen in all MB lines. Significantly higher MAP4K4 
protein expression was detected in DAOY compared to 
UW228 cells. Although considered SHH MB lines [25], 
methylation and expression profiling revealed differences 
between DAOY and UW228 and primary SHH MB 
subgroup tumors. However, recent comparative proteomic 
analysis identified a number of signature proteins and 
revealed enrichment of key components of SHH and WNT 
signaling pathways in DAOY and UW228, respectively 
[26]. We therefore compared expression levels of the five 
NCBI-listed MAP4Ks (MAP4K1-5) in DAOY cells, and 
found MAP4K4 expression levels to be the highest in these 
cells (Supplementary Figure 1C). In both the DAOY and 
the UW228 cells, MAP4K4 protein was detected in and 
around the nucleus and in lamellipodia (Supplementary 
Figure 1D). Using variant-specific siRNAs, we found that 
only the depletion of MAP4K4 or MAP4K5 prevented 
hepatocyte growth factor (HGF)-induced single cell 
migration we previously described in DAOY cells [19] 
(Supplementary Figure 1E). Based on its comparatively 
high expression, we considered MAP4K4 the predominant 
MAP4 kinase in the HGF-c-Met pathway in DAOY cells. 
Using CRISPR/CAS9 we generated DAOY and UW228 
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Figure 1: MAP4K4 is overexpressed in MB tumors. (A) MAP4K4 mRNA U133P affymetrix gene chip micro array expression 
levels in normal tissue samples versus MB tumors. X axis shows absolute intensity values of hybridization reads. Same chip technology 
and internal controls used for all sample groups. Table shows p values of t-tests of the comparisons of the samples indicated in left column 
and top row. (B) MAP4K4 expression analysis in the twelve MB subtypes using data derived from the affymetrix human gene 1.1 ST array 
profiling of the Cavalli gene set of 763 primary MB samples. (C) Comparative MAP4K4 and c-Met expression analysis in the four MB 
subgroups using data derived from the affymetrix human gene 1.1 ST array profiling of the Cavalli gene set of 763 primary MB samples. 
(D) MAP4K4 expression in MB tumor tissue microarray of MB tumor (T) and cerebellum tissue (Cb) samples and H score quantification. 
(E) Anti-MAP4K4 IHC analysis in a non-WNT/non-SHH MB primary tumor, a G3 MB PDX and a Ptch/P53 null SHH model of MB. a’ – 
f’ are 4x magnifications of boxed areas. a’ is healthy cerebellar tissue, and b’ is tumor tissue. c’ and d’ are different zones in same tumor. e’ 
and f’ show MAP4K4-positive neoplastic cells infiltrating the granular layer.
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Figure 2: MAP4K4 contributes to oncogenic phenotype. (A) IBanalysis of MAP4K4 protein expression in various MB cell 
lines and comparative quantification of MAP4K4 protein expression in DAOY and UW228 cells (n=3 i.e.). (B) left: IB analysis of knock-
down efficiency of sgM4K4 in DAOY and UW228 cells. Right: WST assay of DAOY and UW228 cells grown under normal growth 
conditions (triplicate measurements). (C) Clonogenic assay of DAOY cells and quantification of mean colony number and area (n=2 i.e.). 
(D) Clonogenic assay of DAOY control cells or DAOY cells expressing either M4K4-wt or M4K4-K54R and quantification of mean colony 
number and area (n=1). (E) SIA of cells with CRISPR/CAS9-mediated knock-down of MAP4K4 -/+ HGF. (F) Dose-response analysis 
using SIA of DAOY cells -/+ C29 or -/+ GNE-495 in the presence of 20 ng/ml HGF. Pooled data of two independent experiments are 
shown. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 (one-way Anova). (G) SIA with DAOY control, or DAOY ectopically expressing 
either MAP4K4 wild-type (wt), or MAP4K4 kinase-dead mutant (K54R) and frequency distribution for each condition (basal: 100 – 200, 
low: 200 – 300, intermediate: 300 – 400, high: 400 – 500, very high: 500+). IB shows MAP4K4 expression in control and overexpressing 
cells. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 (one-way Anova). (H) CellTox Green cytotoxicity assay measured in detached tumor 
cell spheroids (n=3 i.e.). (I) Representative dot plots of SIA of DAOY and UW228 cells (sgControl and sgMAP4K4_2) exposed to one 
(DAOY) or two (UW228) Gray (Gy) photon irradiation after embedding in collagen. SIA was performed immediately after irradiation -/+ 
20 ng/ml HGF as indicated. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 (one-way Anova).
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cell lines with greatly reduced MAP4K4 expression 
(Figure 2B). Under normal tissue culture conditions, the 
sgMAP4K4_2 (sgM4K4) cells displayed no decreased 
viability compared to sgControl (sgC) cells (Figure 
2B). We next tested the impact of MAP4K4 depletion 
on colony forming activity and clonal growth in DAOY 
cells (Figure 2C). Interestingly, the number and the size 
of colonies were markedly reduced in MAP4K4-depleted 
cells. Supplementing the normal growth medium with 
HGF rescued colony forming activity but not clonal 
growth in DAOY cells (Figure 2C). Overexpression of 
MAP4K4-wt but not of kinase-dead MAP4K4-K54R 
[21] induced colony forming activity and clonal growth 
comparable to HGF treated control cells (Figure 2D). 
Although MAP4K4 depletion also moderately reduced 
the number of colonies in UW228 cells, we measured no 
increase in colony-forming activity or clonal growth in the 
presence of HGF (not shown). However, closer inspection 
of the cells indicated that HGF stimulation caused cell 
scattering and morphological alterations in UW228, which 
in part explained the failure to detect colonies by crystal 
violet staining. These data thus indicate that MAP4K4 
function and HGF signaling are important for attributing 
clonogenic properties to the DAOY cells.
MAP4K4 is required for migration and invasion
To determine whether reduction of MAP4K4 
expression in MB cells is sufficient to impede HGF-
induced collagen I (collagen I) invasion, we quantified 
cell migration and invasion using the spheroid invasion 
assay (SIA [27], Supplementary Figure 2A). MAP4K4 
depletion ablated HGF-induced migration in both DAOY 
and UW228 cells (Figure 2E). Tetracycline-inducible 
short hairpin RNA targeting of MAP4K4 mRNA [19], 
also significantly impaired HGF-, EGF- and IGF-induced 
collagen I invasion but did only moderately affect 
dissemination induced by bFGF (Supplementary Figure 
2B). MAP4K4 kinase inhibition with compound 29 (C29) 
[28] or the second generation MAP4K4 inhibitor GNE-
495 [29] prevented HGF-induced collagen I invasion 
(Figure 2F). Complete repression of HGF-induce collagen 
I invasion was achieved for C29 and GNE-495 by 5 and 1 
μM, respectively. The over-expression of the wt but not of 
kinase-dead MAP4K4 triggered collagen I invasion in the 
absence of HGF similar to control cells in the presence 
of HGF (Figure 2G). As MAP4K4 depletion may affect 
viability of the cells grown under three dimensional 
(3D) conditions and detached of substrate adhesion, we 
measured CellTox Green uptake of DAOY and UW228 
cells grown as non-embedded spheroids. CellTox Green 
uptake was moderately increased in sgM4K4 DAOY 
cells stimulated with HGF (Figure 2H), indicating that 
MAP4K4 depletion combined with GF stimulation in 
the absence of substrate adhesion could cause loss of 
viability.
Sub-lethal doses of radiation can induce pro-
metastatic phenotypes of tumor cells through extrinsic [30, 
31] or intrinsic alterations [32–35]. To explore whether 
MAP4K4 could also be involved in radiation-induced 
migration, we determined the impact of irradiation (IR) 
on collagen I invasion. We found that IR doses of 1 and 2 
Gy increased collagen I invasion of sgC DAOY and sgC 
UW228 cells, respectively (Figure 2I). IR induction of 
collagen I invasion is more modest compared to HGF and 
we observed no synergistic effects when irradiation was 
combined with HGF treatment. Depletion of MAP4K4 
significantly reduced IR-induced collagen I invasion 
both in the absence or presence of HGF. Thus, MAP4K4 
controls a molecular mechanism that is required for 
migration and invasion control but that is not strictly 
dependent on a specific extracellular cue.
MAP4K4 is necessary for brain tissue infiltration 
ex vivo
MB tumor cells grow on and invade heterologous 
brain tissue ex vivo [36]. To test whether depletion of 
MAP4K4 prevented this infiltration process, we implanted 
tumor cell spheroids on the surface of cerebellum slices 
and monitored the dissemination process after five days of 
incubation. We found that sgC cells began to infiltrate the 
brain tissue and to disseminate from the tumor spheroid. 
Depletion of MAP4K4 caused rounded cell morphology 
and markedly (DAOY) or moderately (UW228) reduced 
brain tissue infiltration (Figure 3A). Furthermore, 
MAP4K4 depletion diminished focal, F-actin-positive 
invasion structures in DAOY cells (Supplementary 
Figure 2C). The quantification of the area covered by the 
expanding tumor cells using the anti-human nuclei signal 
(Figure 3B) revealed a further increase in expansion in 
HGF-stimulated DAOY cells, which was abrogated 
in MAP4K4-depleted cells. Consistent with the lower 
expression of MAP4K4 in UW228 cells, the effect of 
MAP4K4 depletion on tissue infiltration in UW228 
cells was less marked (Figure 3B, 3C). Hence, MAP4K4 
function is necessary for brain tissue infiltration and 
the efficacy of the process may depend on the level of 
MAP4K4 in the tumor cells.
HGF-induced actin dynamics and endocytic 
activity require active MAP4K4
MAP4K4 (Supplementary Figure 1D) and EGFP-
Nck-interacting kinase NIK (murine ortholog of human 
MAP4K4 (Figure 4A, Supplementary Movie 1)) co-
localized with dynamic F-actin at the leading edge of 
migrating cells. Expression of EGFP-NIK-k/d (D152N), 
which associated with F-actin-decorated vesicles, reduced 
membrane ruffling and the speed of vesicle trafficking 
(Figure 4A, Supplementary Movie 2). Consistently, 
C29 treatment completely abrogated ruffling and the 
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emergence of F-actin coated vesicles (Figure 4Ba). The 
macropinocytosis marker 70 kDa dextran was taken up by 
the cells (Figure 4Bb). This uptake was enhanced by HGF 
(Figure 4C) or EGF (not shown), suggesting GF induction 
of endocytic activity in the tumor cells. Pre-treatment 
with C29 abrogated HGF-induced dextran up-take to 
a similar level as observed after the pretreatment with 
the macropinocytosis inhibitor ethylisopropylamiloride 
(EIPA) (Figure 4C). Depletion of MAP4K4 impaired 
HGF-induced dextran endocytosis (Figure 4D), whereas 
the overexpression of MAP4K4-wt increased endocytic 
activity to a level similar to HGF-stimulated cells (Figure 
4E). Blockade of endocytosis with EIPA, or Dynasore 
or Dyngo abrogated HGF-induced collagen I invasion 
(Figure 4F). These data showed that MAP4K4 function 
accelerated vesicle trafficking and endocytosis, and that 
latter is necessary to enable HGF-induced collagen I 
invasion.
MAP4K4 promotes integrin activation
Integrin adhesion receptors and their coordinated 
turnover through the endocytic machinery control 
migration and invasion [6, 37]. Expression of collagen 
I (COL1A1), the ligand of the ß1 integrin adhesion 
receptor (ITGb1) is increased in MB compared to normal 
brain regions or normal cerebellum (Figure 5A). Subtype 
analysis indicated that COL1A1 expression is higher 
in SHH-β and SHH-δ compared to the other subtypes 
(Figure 5B), which both displayed also higher MAP4K4 
expression (Figure 1B). Collagen I invasion triggered 
by HGF is associated with activated ß1 integrin (a-
Iß1) enrichment in lamellipodia at the leading edge of 
invading MB cells (Figure 5C, Supplementary Figure 3). 
This HGF-dependent a-Iß1 enrichment was abrogated 
in MAP4K4-depleted cells. Reduced a-Iß1 in collagen 
I-embedded MAP4K4-depleted cells was accompanied 
Figure 3: MAP4K4 promotes brain tissue infiltration. (A) Left:Organotypic cerebellum slice culture with DAOY sgCtrl or DAOY 
sgMAP4K4_2 spheroids implanted. 10x image acquisition of representative slices five days after implantation. Red: Human nuclei, green: 
Lifeact-EGFP, blue: Calbindin. Right: overlay of human nuclei staining of sgC (green) and sgM4K4 (red) spheroids (B) Inverted grey scale 
images of human nuclei staining for comparison of tumor cell expansion in slices. (C) Quantification of areas of human nuclei staining 
shown in B.
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Figure 4: MAP4K4 promotes endocytic uptake. (A) Still images of time lapse movies of DAOY cells transfected with vectors 
expressing lifeact-mCherry and either wild-type or kinase-dead (k/d) EGFP-Nck-interacting kinase NIK (murine MAP4K4, mM4K4-wt 
and mM4K4D152N). Inverted grey scale images show actin and EGFP-MAP4K4. (B) Left: LA-EGFP expressing DAOY cells treated 
with DMSO or MAP4K4 inhibitor C29 (2.5 μM, 48h), LA-EGFP in grey scale. Arrows point to trafficking vesicles. Right: IFA analysis 
of cells exposed to 70 kDa DS red dextran for 30 min. (C) 70 kDa DS red dextran uptake analysis in DAOY cells. Upper: IFA showing 
representative images of DAOY cells 30 min after exposure to dextran + HGF and -/+ EIPA (25 μM) or C29 (2.5 μM). Red: Dextran, green: 
F-actin, blue: DNA. Lower: quantification of HGF-dependent dextran uptake and impact of EIPA or C29 treatment 30 min after exposure 
to dextran (n=3 i.e.). (D) Quantification of HGF-induced 70 kDa DS red dextran uptake in sgC and sgM4K4 DAOY cells (n=2 i.e.). (E) 
Quantification of HGF-induced 70 kDa DS red dextran uptake in control DAOY or DAOY cells overexpressing MAP4K4-wt or MAP4K4-
K54R (kinase-dead, (n=3 i.e.)). (F) SIA of HGF-induced collagen I invasion -/+ EIPA (25 μM) or Dynasore (20 μM) or Dyngo (5 μM) 
treatment (means ± SEM, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 (one-way Anova).
Oncotarget23227www.oncotarget.com
Figure 5: MAP4K4 promotes integrin activation during collagen I invasion. (A) ITGb1 and COL1A1 mRNA U133P affymetrix 
gene chip micro array expression levels in normal tissue samples versus MB tumors. Y axis shows absolute intensity values of hybridization 
reads. Same chip technology and internal controls used for all sample groups. (B) Left: COL1A1 and ITGb1 expression analysis using 
data derived from the affymetrix human gene 1.1 ST array profiling of a set of 763 primary MB samples.Right: Tables showing one-way 
ANOVA repeated measures test using Bonferroni's Multiple Comparison. P-Values < 0.05 were considered significant (* p ≤ 0.05, ** p ≤ 
0.01, *** p ≤ 0.001, **** p ≤ 0.0001). (C) Left: representative images of a-Iß1 in lamellipodia of sgScr (sgC) or sgMAP4K4_2 DAOY cells 
invading collagen I matrix. La-EGFP is in green, a-Iß1 in blue. Inverted grey scale images are shown for better visualization of signals. 
Right: quantification of integrated pixel density of a-Iß1 signal in lamellipodia. (D) IB and quantification of FAK phosphorylation in 
collagen I-embedded DAOY sgC and sgMAP4K4_2 cells -/+ HGF stimulation for 18 h. Mean and SEM of two independent experiments 
are shown. (E) Left: SIA of control or Iß1-depleted cells -/+ HGF. Right: IB of Iß1 after siRNA-mediated depletion in DAOY cells. (F) Dot 
plot and frequency distribution of blocking Iß1 or control ab effect on collagen I invasion in SIA -/+ HGF. (G) Left: Confocal IFA analysis 
depicting a-Iβ1 at basal side of cells. Right:Histograms of FACS comparison of Iß1, a-Iß1 and CD44. expression in suspension (S) or after 
15 min collagen I adhesion (A) in DAOY cells treated either with DMSO or C29.
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by a reduction of FAK activation, which could not be 
rescued by HGF treatment (Figure 5D). Pharmacological 
inhibition of MAP4K4 by C29 or GNE-495 prevented 
HGF-induction of pFAK in collagen-embedded cells 
as well (Supplementary Figure 4). Iß1 is necessary for 
invasion of MB cells as depletion (Figure 5E) or antibody-
mediated blocking of Iß1 (Figure 5F) caused a significant 
reduction in collagen I invasion. MB cell adhesion to 
collagen I-coated surfaces caused a-Iß1 accumulation at 
the basal side of the cells (Figure 5G, left) and led to a 
global increase in surface a-Iß1 within 15 min, compared 
to cells in suspension (Figure 5G, right). Pre-treatment of 
the cells with C29 prevented increased basal and surface 
a-Iß1 in response to collagen binding. C29 pre-treatment 
did not impact Iß1 or CD44 surface expression, suggesting 
that reduced surface a-Iß1 after C29 treatment is not a 
consequence of increased a-Iß1 internalization.
These findings indicate that MAP4K4 pro-migratory 
activity could in part be mediated through its function 
towards Iß1 and possibly through the downstream Iß1 
effector FAK, which is an established promoter of 
proliferation, migration and invasion in MB [38].
MAP4K4 controls c-Met function
FAK cooperates with c-Met in MB [38], and c-Met 
is an established promoter of migration and invasion 
in MB cells [19, 39]. c-Met is endocytosed upon HGF 
binding and c-Met signaling from endocytic vesicles 
mediates growth, survival and cell migration [8]. Blocking 
endocytosis with Dyngo 4a (Supplementary Figure 5A) or 
depletion of MAP4K4 (Figure 6A, Supplementary Figure 
5B) reduced HGF-dependent c-Met and ERK activation 
and repressed FAK phosphorylation. This MAP4K4-
dependent regulation of c-Met function is specific for 
DAOY cells and was not observed in UW228 cells 
(Supplementary Figure 5C). HGF stimulation led to the 
Dyngo 4a-sensitive accumulation of phospho c-Met (pc-
Met) on vesicular structures in the cytoplasm of DAOY 
cells (Supplementary Figure 5D). The concomitant 
increase in cortical F-actin and the appearance of pc-Met-
decorated vesicles in the cytosol was MAP4K4-dependent 
(Figure 6B). These data suggested that activated pc-
Met traffics through intracellular compartments and 
either activation or internalization of c-Met requires 
MAP4K4. To test whether internalization could be 
affected, we biotinylated surface proteins and measured 
the abundance of internalized c-Met-biotin in response to 
HGF stimulation. Raising the temperature from 0 to 37°C 
caused intracellular c-Met-biotin levels to increase within 
30 min (Figure 6C). HGF stimulation further enhanced 
this effect, whereas depletion of MAP4K4 prevented both 
temperature shift- and HGF-induced c-Met internalization. 
To test whether HGF stimulation could affect c-Met 
recycling and its expression at the plasma membrane, 
we compared the levels of cell surface c-Met by flow 
cytometry in unstimulated cells and in cells stimulated 
with HGF for 30 min. We found that HGF stimulation 
caused increased c-Met surface expression (Figure 6D, 
6E). Increased surface c-Met in HGF stimulated cells 
required endocytic trafficking as it was prevented by the 
pre-treatment with Dyngo 4a. Inhibition of MAP4K4 also 
abrogated increased surface expression of c-Met after 
HGF stimulation (Figure 6E), indicating that MAP4K4 
contribution to HGF-c-Met signaling could in part be 
mediated through its potential to increase internalization 
and recycling of c-Met (Figure 6F).
DISCUSSION
We found that the Ser/Thr kinase MAP4K4 is over-
expressed in MB compared to healthy cerebellum tissue. 
This over-expression promotes migratory and invasive 
capabilities of MB tumor cells in response to HGF-c-
Met stimulation or photon irradiation. We furthermore 
show that increased MAP4K4 expression and function 
are associated with enhanced endocytic activity and 
that this activity of MAP4K4 promotes turnover and 
activation of the Iß1 adhesion receptor and of the c-Met 
receptor tyrosine kinase. This study thus revealed a 
novel mechanistic link between MAP4K4 control of 
receptor turnover and activation and tissue infiltration in 
MB (Figure 6F). Furthermore, it identified a potentially 
druggable mechanism to restrict tumor cell migration and 
invasion by interfering with the endocytic processing of 
adhesion and growth factor signaling.
Increased Iß1 and c-Met activation and turnover 
have been linked to cancer progression and metastasis 
[40, 41], by specifically enabling motile and invasive 
capabilities. Our data indicate that MAP4K4 couples 
c-Met signaling to integrin function in invasive 
protrusions, and that it is either involved in inside-out 
signaling for integrin activation or in the trafficking 
of Iß1 to sites of focal contacts. Former is supported 
by the observation that MAP4K4 inhibition prevents 
surface a-Iß1, latter is indicated by our finding that 
a-Iß1 is reduced at basal adhesions sites after MAP4K4 
inhibition. This contrasts with earlier studies that found 
that MAP4K4 causes focal adhesions (FA) dissolution 
by negative regulation of Iß1 through moesin-mediated 
competition for talin binding [42], or through enhanced 
endocytosis by MAP4K4-activated Arf6 activation via 
IQSEC1 [43]. However, increased FA dissolution is 
coupled to increased FA assembly [43], indicating that 
MAP4K4 does not inactivate Iß1 per se but accelerates 
its turnover, which is necessary for cell migration. Indeed, 
MAP4K4 was found on a-Iß1-positive endosomes, which 
suppress anoikis and promote metastasis through FAK 
activation [44]. In MB cells invading collagen gels, we 
observed increased a-Iß1 in HGF-stimulated cells at 
the invasion fronts, where Iß1 turnover is important for 
protrusion extension during growth factor-induced tumor 
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Figure 6: MAP4K4 promotes activation and internalization of c-Met. (A) Quantification of IB analysis of c-Met, Erk1/2 and 
FAK phosphorylation in response to HGF stimulation in sgC or sgMAP4K4_2 cells. XY line plots of mean integrated pixel densities and 
SEM of phospho bands from 3 experiments against time in min after HGF stimulation. (B) Left: Confocal IFA of sgC or sgMAP4K4_2 
cells adhering to poly-L-lysine. pc-Met was detected before (0 min) and after raising temperature from 0° to 37°C -/+ HGF. Insets are 
4x magnifications. Right: bar diagram depicting quantity of internalized pc-Met (number of spots per cell x spot size (n=13 cells, mean 
and SD). (C) Left: IB of internalized, biotinylated c-Met and total c-Met in sgC or sgMAP4K4_2 cells -/+ HGF for the times indicated. 
Right: Integrated pixel densities of internalized biotinylated c-Met relative to total c-Met. (D) FACS analysis of c-Met and CD44 surface 
expression on DAOY and ONS-76 cells without and after 30 min HGF stimulation and compound or siRNA treatments as indicated. (E) 
Median fluorescence intensities of c-Met and CD44 plotted against time of HGF stimulation from FACS analyses shown in D). (F) Scheme 
depicting MAP4K4 control of integrin α5ß1 and c-Met receptor activation and turnover for establishment of pro-metastatic phenotype.
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cell migration. The failure of MAP4K4-depleted cells to 
activate Iß1 in these critical structures and the repression 
of Iß1 activation upon collagen binding in MB cells 
treated with the MAP4K4 inhibitor C29 indicates that FA 
dissolution in endothelial cells [42] and keratinocytes [43] 
could also be the consequence of MAP4K4 activation of 
recycling Iß1. The parallel MAP4K4-dependent activation 
of FAK that we observed in MB indicates that MAP4K4 
functionally links Iß1 to adhesion-induced FAK activation 
and collagen I invasion.
Activated c-Met is rapidly internalized in response 
to HGF, a step critical for downstream signaling [45, 
46]. MAP4K4 depletion or the inhibition of dynamin-
dependent endocytosis abrogate c-Met internalization and 
phosphorylation upon ligand binding and impede collagen 
I invasion. These data indicate that ligand-induced c-Met 
internalization is required for its pro-migratory function 
in MB, highlighting the relevance of endosomal signaling 
of activated GF receptors for cancer progression. The 
common denominator of MAP4K4 regulation of endocytic 
activity, Iß1 activation and c-Met endocytic signaling 
could be F-actin polymerization activity through Arp2/3 
phosphorylation [47]. Indeed, F-actin dynamics have 
recently been implicated in endosomal biogenesis through 
the F-actin linker moesin [48], a previously identified 
substrate of MAP4K4 [49].
MAP4K4 depletion also prevents IR-induced 
migration and invasion. The impact of MAP4K4 on 
integrin activation and RTK activation and turnover 
could indicate that these processes are also relevant 
for irradiation-induced migration and invasion in MB. 
Alternatively, depletion of MAP4K4 could affect F-actin 
dynamics during IR-induced migration and thereby ablate 
the formation of invasive protrusions. This scenario is 
supported by the observation that depletion of MAP4K4 
in UW228 cells also blocked IR–induced collagen I 
invasion, a treatment that did not affect endocytic turnover 
in these cells. However, further mechanistic insights will 
be necessary for the discovery of a rational approach 
targeting IR-induced migration.
Although depletion of MAP4K4 prevented HGF- 
or IR-induced migration in the two different SHH MB 
lines, we also observed marked differences between them. 
Most strikingly is the markedly higher MAP4K4 protein 
expression in DAOY cells. A recent proteomic study, 
which compared the proteome of DAOY and UW228 [26] 
found a number of SHH signature proteins specifically up-
regulated in DAOY cells and a concomitant enrichment 
of key components of the SHH signaling pathway. 
In contrast, protein expression and signaling protein 
enrichment in UW228 cells indicated WNT pathway 
activation. However, the diverging dependence on 
MAP4K4 function in the two cell lines is likely due to 
the increased MAP4K4 expression levels in DAOY, 
which may be causative for its impact on the endocytic 
machinery. This would imply that MAP4K4 control of 
migration and invasion is involved in separate biological 
pathways, one depending on moderate MAP4K4 
expression (e.g. control of F-actin polymerization, which 
we found in both DAOY and UW228 cells [19]) and 
the other - endocytic vesicle trafficking and control of 
integrin ß1 and c-Met receptor activation and function – 
on elevated MAP4K4 expression.
Thus, the identification of endocytic activity as 
a novel effector function of MAP4K4 for migration 
and invasion control opens new conceptual avenues 
for tailored therapeutic interventions to selectively 
target metastatic tumor progression independent of the 
underlying oncogenic alteration.
MATERIALS AND METHODS
Ethics approval and consent to participate
Human subjects
Informed consent was obtained from subjects and 
all research involving subject’s material was conducted 
under appropriate review/privacy board protocols of the 
Kantonale Ethikkommission Zürich (Ethics Commission 
of the Canton of Zürich, Switzerland). The use of patient 
tumour material for diagnostic and prognostic analysis 
was approved by the Kantonale Ethikkommission 
Zürich.
Mouse maintenance
Mouse protocols for organotypic brain slice culture 
were approved by the Veterinary Office of the Canton 
Zürich. Wild type C57BL/6JRj pregnant females were 
purchased from Janvier Labs and were kept in the animal 
facilities of the University of Zürich Laboratory Animal 
Center.
Cell culture
DAOY human MB cells (ATCC, Rockville, MD, 
USA), UW228 [50] (provided by John Silber (Seattle, 
USA)) and ONS-76 [51] culture and generation of DAOY 
LA-EGFP and UW228 LA-EGFP cells are described in 
[19]. Cell lines were authenticated less than six months 
before initiation of experiments by SNP profiling 
(performed by Multiplexion, Germany). ONS-76 control 
cells were grown as described in [52].
RNA expression analysis by qRT-PCR
Total RNA was isolated using RNeasy Mini Kit 
(Qiagen, Basel, Switzerland). 1 μg of total RNA was 
used as a template for reverse transcription, which was 
initiated by random hexamer primers. The cDNA synthesis 
was carried out using High capacity cDNA Reverse 
Transcription Kit (Applied Biosystems). qRT-PCR was 
performed under conditions optimized for the ABI7900HT 
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instrument, using TaqMan® Gene Expression Master Mix 
(4369016, Applied Biosystems). The ΔΔCT method was 
used to calculate the relative gene expression of each gene 
of interest.
MAP4K4 gene expression analysis
Gene expression data were obtained from the R2 
genomics and visualization platform (http://hgserver1.
amc.nl/cgi-bin/r2/main.cgi). Gene expression levels are 
expressed as logical values without transformation or as 
the 2nd log of it. The following datasets were used: Normal 
Brain regions - Berchtold - 172 - MAS5.0 - u133p2; 
Normal cerebellum - Roth - 9 - MAS5.0 - u133p2; Tumor 
Medulloblastoma (SHH) - Pfister - 73 - MAS5.0 - u133p2; 
Tumor Medulloblastoma Ependymoma - denBoer - 51 - 
MAS5.0 - u133p2; Tumor Medulloblastoma PLoS One 
- Kool - 62 - MAS5.0 - u133p2; Tumor Medulloblastoma 
public - Delattre - 57 - MAS5.0 - u133p2; Tumor 
Medulloblastoma - Gilbertson - 76 - MAS5.0 - u133p2; 
Tumor Glioma pediatric - Paugh - 53 - MAS5.0 - u133p2 
public.
Immunohistochemistry (IHC)
IHC of FFPE samples, of the MB Tissue Microarray 
(TMA) and normal brain sections was performed by 
Sophistolab (Muttenz, Switzerland) on a Leica BondMax 
instrument using Refine HRP-Kits (Leica DS9800): 
Epitope retrieval (ER)-solution 2 for 10 minutes at 95°C, 
ER-solution 2 for 20 minutes at 100°C and ER-solution 2 
for 30 minutes at 100°C. The TMA slides were captured 
digitally using Axio Observer 2 mot plus fluorescence 
microscope (Zeiss, Munich, Germany). Expression was 
assessed blindly by an experienced pathologist at 5x to 
20x magnifications and classified using H scores as high, 
moderate, low and negative expression.
Immunofluorescence
Cells were processed for immunofluorescence 
analysis (IFA) as described in [19]. Images were acquired 
either on an Axioskop 2 fluorescence microscope (Zeiss) 
or an SP8 confocal microscope (Leica).
Transfection and ectopic protein expression
DAOY cells were transiently transfected using 
Jet-Pei (101-10 Polyplus), with plasmids encoding 
lifeact [53] (LA)-mCherry (pLenti-LA-mCherry) and 
either pEGFP-C2 NIKwt (wild-type Nck-interacting 
kinase EGFP-NIK (murine MAP4K4)) or pEGFP-C2 
NIKD152N (murine MAP4K4-kinase dead (mM4K4-
k/d)) [49]. For ectopic expression of human MAP4K4, 
pCDNA3 vector encoding wt or K54R MAP4K4 [21] was 
transfected into DAOY cells as described above. Cell lines 
stably expressing MAP4K4-wt or MAP4K4-K54R were 
generated by neomycin selection of transfected cells.
RNA interference
The cells were transfected using Dharmafect 4 
transfection reagent (Dharmacon) with either Silencer 
Select siRNA specific for MAP4K1-5 or negative control. 
30 h after transfection, the cells were re-seeded for single 
cell migration analysis (see 2.10). shRNA mediated 
depletion using Tet-inducible, shRNA-mediated MAPK4-
depletion was performed as described in [19].
MAP4K4 depletion by LentiCRISPR
Cloning of three different sgRNAs (sequence 
listed in supplemental materials) into BFP expressing 
LentiCRISPR plasmids was performed with a single-
tube restriction and ligation method as described in [54]. 
Production of lentiviral vectors was performed according 
to the standard protocol. In brief, 293T cells were 
transfected using HEPES-buffered saline solution (HeBS) 
and 0.5 M calcium phosphate with LentiCRISPR, pVSV, 
pMDL, and pRev (latter three kindly provided by Oliver 
Pertz, Bern, Switzerland) in a ratio of 4.5:1.5:3:1. The 
media was changed after 12 h and the virus was collected 
at 72 h after transfection of plasmids. Viral transductions 
were performed using hexadimethrine bromide (H9268, 
Sigma-Aldrich). Depletion activity of the sgRNA 
sequences was tested in DAOY cells by immunoblot 
(IB). sgMAP4K4_0 was ineffective. The most effective 
sequence (sgMAP4K4_2 targeting exon 4) was chosen for 
further experiments.
Live cell imaging
mCherry and EGFP fluorescence were acquired in 
a temperature and CO2-controlled SP8 Leica confocal 
microscope with a 63× multi-immersion objective. 60 
Z-stacks of six images each were acquired (0.34 μm 
Z-distance, 15 s intervals, 15 min). Average intensity 
projections were assembled into QuickTime movies 
(10 fps, 150x speed). F-actin dynamics in DAOY cells 
stably expressing LA-EGFP [19] were recorded with a 
temperature- and CO2 controlled Zeiss Axio Observer 
epifluorescence microscope using a glycerol 63x objective 
(30 s intervals, 60 min).
Single cell motility assay
Cells were seeded in 96-well glass bottom plates (In 
Vitro Scientific) in cell culture medium without FCS for 
18 h. Cell motility was acquired thereafter -/+ HGF (20 ng/
ml) using a temperature- and CO2-controlled ImageXpress 
Micro 2 microscope for 18 h. Cell speed (path length/time) 
was determined by manually tracking the cells at 5 min 
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intervals for 6 - 18 h using ImageJ software (National 
Institutes of Health, USA).
Spheroid invasion assay (SIA) and irradiation
1000 cells in 100 μl per well were seeded in 96 well 
Corning® Spheroid microplate (CLS4520, Sigma-Aldrich, 
DAOY cells) or in cell-repellent 96 well microplate 
(650790, Greiner Bio-one, UW228 cells) and assay was 
performed and quantified exactly as described in [27]. 
For the Iβ1 blockage, cells were treated with 10 ug/ml Iβ1 
blocking antibody or control mouse IgG for 2 h at 37°C 
before embedding in collagen I. Irradiation was performed 
using a Gulmay (Xstrahl) 200-kV x-ray unit at 1 Gy/min 
(kVp 200 kV; half-value layer (HVL) Z 1.03 mm Cu; 
Filter: 1 mm Al and 0.45 mm Cu).
pFAK analysis in collagen I embedded cells
1’500’000 DAOY wild type, sgC or sgM4K4 
cells were seeded per well in low adhesion 6 well plate 
CellStar® (Greiner Bio-One, 657970) and incubated 
overnight at 37°C. Formed aggregates were embedded in 
1 mL of collagen I solution and incubated 1 hour at 37°C 
to let the collagen polymerize. Compound treatments were 
as follows: C29 (5 μM, 18h), GNE-495 (1.2 μM, 18 hours) 
or an equivalent volume of DMSO as control -/+ HGF 
(20 ng/ml) at 37°C. Embedded aggregates were lysed 
using 500 μL of G-LYSA™ Lysis buffer (Cytoskeleton, 
GL36) and processed for immunoblot (IB) with FAK, 
pFAK and tubulin antibodies. Loading was normalized 
using tubulin detected on the same membrane and pFAK 
levels were normalized using total FAK. Relative pFAK 
was determined compared to solvent or compound-treated 
cells without HGF.
Colony formation assay
DAOY cells were seeded at a density of 400 
cells/well in a 6-well plate in complete growth medium 
containing 10% FBS. The cells were allowed to adhere for 
24 h, and the medium was replaced with fresh complete 
growth medium -/+ HGF (20 ng/ml). The cells were 
cultured at 37°C for 10 days with medium changes every 
third or fourth day. The colonies were fixed in methanol 
for 10 min at -20°C and then stained with 0.5% crystal 
violet for 20 min. The number and the area of the colonies 
were quantified using ImageJ.
Iß1 activation by ligand engagement (replating 
assay) [44]
Cells were serum starved for 24 h, detached with 
HyQTase and kept in suspension in serum-free medium 
for 1 h. Dyngo4a or C29 or a corresponding volume of 
DMSO were added to cells 15 min before re-plating on 
collagen type I (5 μg/ml) coverslips for 15 min at 37°C. 
Cells were subsequently fixed with 4% PFA and proceeded 
for IFA using a Leica SP8 confocal microscope.
β1-integrin surface expression and activation 
analysis
Serum-starved DAOY cells were pre-treated with 
C29 (5 μM, 5 hours) or an equivalent volume of DMSO 
as control and detached with HyQTase, maintained in 
suspension for 1 hour at 37°C and seeded onto collagen-
coated dishes for 15 min. 100,000 cells were then scraped 
into modified Tyrode’s buffer, fixed with 1 volume of 4% 
paraformaldehyde/1mM MgCl2 in PBS on ice and then 
incubated for 20 min on ice with anti-a-Iβ1 12G10, or 
anti-total Iβ1, or anti-CD44 or isotype controls. After one 
wash with PBS, cells were incubated with the secondary 
antibodies on ice for 20 min and after one wash with PBS 
analyzed using a BD Accuri C6 Flow Cytometer.
Organotypic brain slice culture
Cerebellar slices were prepared from P10 
C57BL/6JRj mouse pups. After 15 days in culture, 
sgControl and sgMAP4K4_2 tumor cell spheroids were 
implanted and then grown on the slices for five days as 
described in [36]. For HGF treatment, the feeding medium 
was supplemented with 20 ng/ml HGF. Purkinje cells 
were detected with anti-Calbindin staining and human 
nuclei detected with anti-human nuclei antibody. Cell 
dissemination was quantified as described in [27] using 
the human nuclei florescence with threshold settings 
adapted to the human nuclei signal intensities.
Dextran uptake assay
2,000 DAOY LA-GFP cells were seeded per well 
in 96 well microplate μClear® (Greiner Bio-One, 655090) 
and incubated overnight at 37°C. Medium was replaced 
with serum-free medium. After overnight incubation at 
37°C, cells were treated with C29 (2.5 μM, 5h), EIPA (25 
μM, 30 min) or an equivalent volume of DMSO as control. 
Starvation medium was replaced with starvation medium 
containing 70 kDa TMR-Dextran -/+ HGF (20 ng/ml) 
and the respective inhibitors, and cells were incubated 
at 37°C for 30 min. PFA-fixed cells were imaged using 
Zeiss Axio Observer microscope using a 40x objective. 
25 tiles per well were acquired and used for quantification. 
Cell area was determined using the EGFP-channel signal. 
The relative dextran uptake was calculated as the TMR-
Dextran integrated pixel density divided by the cell area 
(pixels) and compared to the control.
c-Met internalization assay
Internalization of c-Met receptor were measured 
using biotinylation assay as described in [55]: Briefly, 
surface receptors of serum-starved sgControl or 
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sgMAP4K4_2 DAOY cells were biotinylated using EZ-link 
Sulfo-NHS-LC-biotin (sulfosuccinimidyl-6-(biotin-amido) 
hexanoate; Thermo Scientific, Pittsburg, PA). Cells were 
incubated with or without HGF (20 ng/mL) for 0, 5, 15 and 
30 min. After biotinylation and internalization steps, cells 
were lysed in RIPA buffer and biotin was precipitated from 
500-800 μg of total protein using Pierce™ Streptavidin 
Magnetic Beads (Thermo Scientific, Pittsburg, PA). 
Proteins were eluted form beads with RotiLoad. Eluted 
proteins and total cell lysate were processed for IB.
c-Met surface expression analysis
DAOY or ONS-76 cells were seeded in Poly-L-
Lysine-coated dished and starved for 24 hours. The cells 
were pre-treated with C29 (5 μM, 5 hours), Dyngo 4a 
(5 μM, 15 minutes) or an equivalent volume of DMSO 
as control and then incubated with or without HGF (20 
ng/ml) for 5 or 30 minutes. Cells were detached with 
HyQTase, resuspended into modified Tyrode’s buffer 
and fixed with 1 volume of 4% paraformaldehyde/1mM 
MgCl2 in PBS on ice for 15 min and then incubated for 
20 min on ice with anti-c-Met, or anti-CD44 or isotype 
control. Samples were acquired using BD LSRFortessa 
flow cytometer (BD Bioscience). Where indicated the cells 
were transfected with siRNA 48 h before HGF stimulation.
c-Met antibody feeding assay, p-c-Met 
internalization
DAOY LA-EGFP cells were seeded in starvation 
medium onto Poly-L-Lysine. 18 h later, cells were 
incubated with anti-c-Met antibody (1:50) for 1 h at 4°C. 
Cells were washed 3x with ice cold PBS and then incubated 
-/+ HGF for 30 min at 37°C. Cells were then fixed stained 
with anti-p-c-Met (1:50) and subjected to IFA.
Cell proliferation WST-1 assay
The metabolic activity and the proliferation of 
the cells were determined using the WST-1 assay kit – 
Roche (11644807001, Sigma Aldrich) according to the 
manufacturer’s instructions. In brief, 2500 cells/100μl/
per well (for up to 72 h incubation) and 750 cells/100μl/
per well (for up to 120 h) were seeded in Greiner Bio-
One μ-clear 96 well plates (655090, Greiner Bio-One) 
and incubated overnight at 37°C. Following appropriate 
incubation for each timepoint, 10 μl of the WST-1 reagent 
was added to each well (final concentration of WST-1 
reagent per well is 1:10) and incubated at 37°C for 30 
minutes. The absorbance was then measured at 440 nm.
Statistical analysis
Unpaired student’s t-test was used to test 
significance of differences between samples acquired in 
three independent experiments. For all other analyses, one-
way ANOVA repeated measures test using Bonferroni's 
Multiple Comparison using Prism software was 
performed. P-Values < 0.05 were considered significant (* 
p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001).
CONCLUSIONS
This study describes enhanced endocytosis of 
adhesion and growth factor receptors in the tumor cells 
as a novel pathogenic mechanism promoting receptor 
tyrosine kinase signaling, migration and invasion in 
medulloblastoma. It identified the proto-oncogenic ser/
thr kinase MAP4K4, which is overexpressed in one 
third of MB tumors, as an important mediator of this 
process. Thus, MAP4K4 control of endocytic activity 
may represent a novel druggable mechanism to restrict 
metastatic dissemination of MB and of other tumors with 
elevated MAP4K4 expression.
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